UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT
TO RULES 13d-1(b)(c), AND (d) AND AMENDMENTS THERETO FILED
PURSUANT TO RULE 13d-2(b)
(Amendment No. 1)1
Sanofi Synthélabo
Shares, nominal value 2 euro
80105N 10 52
December 31, 2003
Check the following box to designate the rule pursuant to which this Schedule is filed:
o | Rule 13d-1(b) | |
o | Rule 13d-1(c) | |
x | Rule 13d-1(d) |
1 The remainder of this cover page shall be filled out for a reporting persons initial filing
on this form with respect to the subject class of securities, and for any subsequent amendment containing
information which would alter the disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be deemed to
be filed for the purpose of Section 18 of the
Securities Exchange Act of 1934 (Act) or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see
the Notes).
2 This CUSIP number applies to the Issuers American Depositary Shares, each representing one-half of one ordinary share.
SIGNATURE | ||||||||
IDENTIFICATION AND CLASSIFICATION OF MEMBERS | ||||||||
IDENTIFICATION AND CLASSIFICATION OF MEMBERS | ||||||||
DOCUMENTS INCORPORATED BY REFERENCE |
13G | ||||||
CUSIP No. 80105N 10 5 | Page 2 of 7 | |||||
1. | Name of Reporting Person: Total S.A. |
I.R.S. Identification Nos. of above persons (entities only): |
||||
2. | Check the Appropriate Box if a Member of a Group:* | |||||
(a) | x | |||||
(b) | o | |||||
3. | SEC Use Only: | |||||
4. | Citizenship or Place of Organization: France |
|||||
Number of Shares Beneficially Owned by Each Reporting Person With | ||||||
5. | Sole Voting Power: - 0 - | |||||
6. | Shared Voting Power: 178,476,513 (shares carry double voting rights) (see Item 4) | |||||
7. | Sole Dispositive Power: - 0 - | |||||
8. | Shared
Dispositive Power: 178,476,513 (shares carry double voting rights) (see Item 4) | |||||
9. | Aggregate Amount Beneficially Owned by Each Reporting Person: 178,476,513 |
|||||
10. | Check
if the Aggregate Amount in Row (9) Excludes Certain
Shares:* x See Exhibit A attached hereto. |
|||||
11. | Percent of Class Represented by Amount in Row (9): 24.35% (based on the number of shares reported by the Issuer as being outstanding as of December 31, 2003); percent of voting rights, 34.8% (based on the number of voting rights reported by the Issuer as being outstanding as of May 19, 2003) | |||||
12. | Type
of Reporting Person:* HC | |||||
2
Item 1(a). | Name of Issuer: | |||||||
Sanofi Synthélabo | ||||||||
Item 1(b). | Address of Issuers Principal Executive Offices: | |||||||
174, avenue de France 75013 Paris France |
||||||||
Item 2(a), (b) and (c). | Name of Person Filing; Address of Principal Business Office or, if None, Residence; and Citizenship: | |||||||
This statement is being filed by Total S.A., a company organized under the laws of France. Total S.A.s principal business is oil, gas and chemicals. The address of Total S.A.s principal business and office is 2, place de la Coupole, La Défense 6, 92078 Paris La Défense Cedex, France. Total is making an individual filing on Schedule 13G in accordance with Rule 13d-1(k)(2) under the Securities Exchange Act of 1934 and is responsible solely for the information contained in its individual filing. | ||||||||
Item 2(d). | Title of Class of Securities: | |||||||
Shares, nominal value 2 euro | ||||||||
Item 2(e). | CUSIP Number: | |||||||
80105N 10 5 | ||||||||
Item 3. | If this Statement is Filed Pursuant to Rule 13d-1(b), or 13d-2(b) or (c), Check Whether the Person Filing is a: | |||||||
(a) | o | Broker or Dealer registered under Section 15 of the Exchange Act. | ||||||
(b) | o | Bank as defined in Section 3(a)(6) of the Exchange Act. | ||||||
(c) | o | Insurance company as defined in Section 3(a)(19) of the Exchange Act. | ||||||
(d) | o | Investment company registered under Section 8 of the Investment Company Act. | ||||||
(e) | o | An investment advisor in accordance with Rule 13d-1(b)(1)(ii)(E). | ||||||
(f) | o | An employee benefit plan or endowment fund in accordance with Rule 13d-1(b)(1)(ii)(F). | ||||||
(g) | o | A parent holding company or control person in accordance with Rule 13d-1(b)(1)(ii)(G). | ||||||
(h) | o | A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act. | ||||||
(i) | o | A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act. | ||||||
(j) | o | Group, in accordance with Rule 13d-1(b)(l)(ii)(J). | ||||||
Item 4. | Ownership | |||||||
As of December 31, 2003, Total S.A. beneficially owned the following shares indirectly through its subsidiaries Elf Aquitaine and Valorisation et Gestion Financière: |
Amount beneficially owned: | 178,476,513 | ||||
Percent of class: | 24.35%; percent of voting rights, 34.8% | ||||
Number of shares as to which such person has: | |||||
Sole power to vote: | -0- | ||||
Shared power to vote: | 178,476,513 (these shares carry double voting rights) | ||||
Sole power to dispose of: | -0- | ||||
Shared power to dispose of: | 178,476,513 |
3
On April 9, 1999, Elf Aquitaine (now a subsidiary of Total S.A.) entered into a shareholders agreement with LOréal with respect to the parties shareholdings in the Issuer. As disclosed in the Issuers Form 20-F filed on June 25, 2002, the parties have agreed in the shareholders agreement not to sell any of the shares covered by the shareholders agreement, except in certain limited circumstances, such as the commencement of a tender offer for the Issuers shares. Presently, the 19.43% of the Issuers share capital held by each of the Total Group and LOréal are subject to a number of restrictions under the shareholders agreement, in particular regarding share transfers, while shares held in excess of this percentage by either group are subject to certain more limited restrictions. The shareholders agreement also contains provisions relating to the composition of the Issuers board of directors and cooperation among the parties respective appointees to the Issuers board of directors. The parties amended the shareholders agreement on November 24, 2003, providing, inter alia, for the termination of the shareholders agreement effective December 2, 2004. As from December 2, 2004, Total and LOréal will cease to be members of a Group in respect of the Issuers shares. On January 25, 2004, Total and LOréal entered into a Protocol of Agreement, whereby the parties waived certain rights to effect the procedure set forth in Annex 2 to the shareholders agreement in connection with certain proposed offers made by the Issuer for the shares of Aventis. | ||
The shareholders agreement, included as Exhibit 2.2 to the Issuers Form 20-F for the fiscal year ended December 31, 2002 (File Number 001-31368), and the amendment thereto included as Exhibit 10.2 and the protocol included as Exhibit 10.3, in each case to the Issuers Form F-4 filed January 29, 2004 (File Number 333-112314), are incorporated by reference as Exhibit C hereto. Total disclaims beneficial ownership of any shares of the Issuer that LOréal owns. See also Item 8 of this Schedule 13G and Exhibit B thereto. | ||
Item 5. | Ownership of Five Percent or Less of a Class. | |
If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following [ ]. | ||
Item 6. | Ownership of More than Five Percent on Behalf of Another Person. | |
Not Applicable. | ||
Item 7. | Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company. | |
Of the 178,476,513 shares being reported hereunder, Total S.A. indirectly has the power to vote and dispose of 178,476,473 shares being reported on hereunder through two subsidiaries identified in Exhibit A attached hereto, and the remaining 40 shares through certain other persons. | ||
Item 8. | Identification and Classification of Members of the Group. | |
See Exhibit B attached hereto. | ||
Item 9. | Notice of Dissolution of the Group. | |
Not Applicable. | ||
Item 10. | Certifications. | |
Not Applicable. |
4
SIGNATURE
After reasonable inquiry and to the best of the undersigneds knowledge and belief, the undersigned certifies that the information set forth in this statement is true, complete and correct.
TOTAL S.A. | |||||
By: | /s/ Charles Paris de Bollardière | ||||
Name: Charles Paris de Bollardière Title: Treasurer |
Date: February 13, 2004
5